Mesothelioma Cancer Centers
OHSU Knight Cancer Institute
Doctors Affiliated with this Treatment Facility
The Knight Cancer Institute at the Oregon Health and Science University (OHSU) is a National Cancer Institute-designated Clinical Cancer Center, named as such in 1997. Part of the only health sciences academic institution in the state, the Knight Cancer Center strives to "heal, teach, and discover" and its 200 members work together to develop new methods for diagnosing cancer, new and better treatments for the disease, and strategies for cancer prevention.
The center's research staff focuses on four different programs, each of which interfaces with clinical care at the OHSU Hospital. These programs include cancer biology, hematologic malignancies, solid tumors, and cancer prevention and control.
Clinical cancer care at the Oregon Cancer center at OHSU includes a multi-disciplinary approach to treating patients. Those afflicted with cancer, like malignant mesothelioma, will meet with specialists who are experts in their particular form of the disease as well as surgical and medical oncologists, radiation therapists, pathologists, nurses, physician's assistants, and support personnel including psychologists and other counselors. These teams of experts meet weekly to assess each patient's prognosis and to update or change and protocols.
The Solid Tumor Oncology Department handles any mesothelioma patients that come to OHSU, and the teams in this department devise treatment strategies that include the latest in minimally-invasive surgical techniques, chemotherapy drugs like Cisplatin, Alimta®, and Carboplatin, and targeted radiation.
Clinical trials are regularly offered and doctors can determine whether or not each patient is qualified for participation. In addition, Knight Cancer Center provides support groups for cancer patients and their families, financial guidance when needed, referrals to hospice and palliative care programs, and a variety of educational services for patients and the community-at-large.Sources
Oregon Cancer Center